Armstrong, Jonathan K <br/><br/>
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients.  [electronic resource] 

 -  Cancer  Jul 2007 
 - 103-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.22739  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Agglutination Tests--methods<br/>Antibodies--blood<br/>Antineoplastic Agents--adverse effects<br/>Asparaginase--immunology<br/>Child<br/>Female<br/>Flow Cytometry--methods<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Polyethylene Glycols--pharmacokinetics<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood<br/>Reproducibility of Results<br/>Treatment Outcome